Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Iterum Therapeutics plc
Iterum Therapeutics Reports Employment Inducement Grant
January 11, 2023
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
December 15, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
November 10, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022
November 03, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
October 20, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Iterum Therapeutics to Present Data at IDWeek 2022
October 17, 2022
From
Iterum Therapeutics plc
Via
GlobeNewswire
Tickers
ITRM
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.